- Presentations
- 3
- Markets
- 1
Cotempla XR-ODT is a brand of Methylphenidate marketed by Neos Therapeutics Brands, with 3 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Methylphenidate
- Brand owner
- Neos Therapeutics Brands
- Registered in
- United States
- Strengths and forms
- 17.3 mg orally disintegrating tablet, 25.9 mg orally disintegrating tablet, 8.6 mg orally disintegrating tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Cotempla XR-ODT 17.3 mg orally disintegrating tabletOral | Neos Therapeutics Brands | US FDA | Available on request |
| Cotempla XR-ODT 25.9 mg orally disintegrating tabletOral | Neos Therapeutics Brands | US FDA | Available on request |
| Cotempla XR-ODT 8.6 mg orally disintegrating tabletOral | Neos Therapeutics Brands | US FDA | Available on request |
Equivalent brands
Other brands of Methylphenidate.
RelexxiiVertical PharmaceuticalsMetadate CDLannettmethylphenidate hydrochloride CDLannettJORNAY PM Extended-ReleaseIronshore PharmaceuticalsMethylphenidate Hydrochloride (LA)Dr. Reddy's LaboratoriesConcertaJanssen PharmaceuticalsDaytranaNoven TherapeuticsQuilliChew ERNextWave PharmaceuticalsRitalinSandozMethylinShionogiQuillivant XRNextWave Pharmaceuticals
Brand names and trademarks belong to their owners and are used only to identify products.
Request Cotempla XR-ODT
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.